Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Capital/Financing Update 2018

Mar 13, 2018

65122_rns_2018-03-13_d052322d-346e-4cb9-bbfa-1ac4cca8d93b.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

14 March 2018

Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)

Immutep Limited (ASX:IMM) (the Company ) by Appendix 3B lodged today, confirmed the issue of 326,192,381 fully paid ordinary shares.

In accordance with Listing Rules 3.10.5A and 7.1A.4(b), the Company makes the following disclosures:

  • a) The dilutive effect of the offer on existing shareholders of the Company is as follows:
Shares on issue Dilution
Fully paid ordinary shares (‘Shares’) on issuepre-placement 2,399,329,199
Shares issued under LR 7.1 86,259,462 3.17%
Shares issued under LR 7.1A 239,932,919 8.80%
Total Placement 326,192,381 11.97%
Total Shares on issue post issue 2,725,521,580 -
  • b) The Company issued shares as a placement to the participating institutional & sophisticated investors as it considered this the most efficient mechanism for raising funds at the time.

  • c) The placement was not underwritten.

  • d) Total fees and costs incurred in connection with the placement are estimated at $10,000.

Immutep Ltd , Level 12, 95 Pitt Street, Sydney NSW 2000 Phone: +61 2 8315 7003 Fax: +61 2 8569 1880 www.immutep.com ABN: 90 009 237 889